Report of safety analysis in a randomized phase III study comparing S-1 alone with S-1 plus CDDP in advanced gastric cancer (The SPIRITS trial. TS-1 advanced gastric cancer clinical trial group)

被引：2

作者：

Hara, T. ^{[1
]}

Koizumi, W. ^{[2
]}

Narahara, H. ^{[3
]}

Takagane, A. ^{[4
]}

Akiya, T. ^{[5
]}

Takagi, M. ^{[6
]}

Miyashita, K. ^{[7
]}

Nishizaki, T. ^{[8
]}

Kobayashi, O. ^{[9
]}

机构：

[1] Kouseiren Takaoka Hosp, Dept Surg, Toyama, Japan

[2] Kitasato Univ, Sch Med, Dept Gastroenterol, Kanagawa, Japan

[3] Osaka Med Ctr Canc Cardiovascular Dis, Dept Gastroenterol, Osaka, Japan

[4] Iwate Med Univ, Dept Surg, Iwate, Japan

[5] Gunma Prefectural Canc Ctr, Dept Gastroenterol, Gunma, Japan

[6] Shizuoka Prefectural Gen Hosp, Dept Surg, Shizuoka, Japan

[7] Natl Hosp Org, Nagasaki Med Ctr, Dept Surg, Nagasaki, Japan

[8] Matsuyama Red Cross Hosp, Dept Surg, Ehime, Japan

[9] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Kanagawa, Japan

来源：

EJC SUPPLEMENTS | 2007年 / 5卷 / 04期

关键词：

D O I：

10.1016/S1359-6349(07)71019-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3516

引用

页码：264 / 264

页数：1